PRRT2 and fibrosis: The impact was shown by inhibited canonical pathways (Z-score based) including hepatic fibrosis signaling, NF-kB signaling, PKCθ signaling in T cells, necroptosis, and increased PD-1/PD-L1 pathway (Figure 2G).